Analysis of survival signaling and its application for a new therapeutic strategy of cancers in gastro-intestinal tract and liver.
生存信号分析及其在胃肠道和肝癌新治疗策略中的应用。
基本信息
- 批准号:14370182
- 负责人:
- 金额:$ 8.45万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Different from another form of cell death called necrosis, a morphological-defined cell death, called apoptosis, has been recently observed. Apoptosis is initiated by death ligands, or by a variety of stimuli including chemotherapy, and y-irradiation.Apoptosis is strictly controlled by a variety of mechanisms at different levels. Inside the cells, the members of Bcl-2 family constitute a first class of regulatory proteins, which act at the mitochondrial level. BAD, a member of Bcl-2 family exerts its pro-apoptotic action on the mitochondrion in the non-phosphorylated state, and forms inactivating dimmers with Bel-XL or Bcl-2 to promote apoptosis. Phosphorylated BAD dissociates from the heterodimeric complex with Bel-XL or Bcl-2,restoring Bel-XL or Bcl-2 function, and activating cell survival signaling. Recent works have indicated that activated BAD kinases including Akt or PKA (A kinase) in the tumor cells play a key role in apoptosis resistance through BAD phosphorylation. We investig … More ated the involvement of intracellular survival signals in human hepatocellular carcinoma(HCC). Both Akt and PKA. were activated in HCCs compared to adjacent non-involved tissues. BAD protein was highly phosphorylated in HCCs compared to uninvolved liver. There was significant correlation between Akt or PKA activity and BAD phosphorylation in HCCs. In addition, inhibitors of these signal transduction cascade induced programmed cell death in human hepatoma cell lines. These observations indicate that survival signal suppresses programmed cell death via BAD phosphorylation in human HCCs, and suggest that it may promote escape from apoptosis to allow HCC tumor progression.On the other hand, mitogen-activated protein kinase(MAPK) cascade is activated in response to various extracellular stimuli. We examined involvement of p38 MAPK, a MAPK super family, cascade in human HCCs and hepatoma cell lines. In HCCs,MKK6,which is upstream of p38 MAPK, and p38 MAPK activities were significantly lower compared to non-tumorous lesions. There was a significant positive correlation between p38 MAPK and MKK6 activity. Moreover, there was a positive correlation between p38 MAPK and caspase-3 activity. HCCs measuring over 20 mm exhibited lower levels of MKK6 and p38 MAPK activity than did smaller tumors. MKK6 transfection increased p38 MAPK activity, cytochrome c release from the mitochondria to the cytosol, and caspase-3 activity, accompanied by apoptosis in hepatoma cell lines. In contrast, a p38 MAPK specific inhibitor prevents MKK6-induced apoptosis in hepatoma cell lines. These results indicate that the p38 MAPK cascade is consistent with induction of a programmed cell death pathway in hepatoma cells, and suggest that reduction of the p38 MAPK cascade may account, in part, for escape from apoptosis, leading to the progression of human HCC.Taking together, the modulation of activated survival signals and diminished apoptotic signals may serve as a new therapeutic strategy for cancer therapy. Less
与另一种称为坏死的细胞死亡不同,最近观察到了一种形态定义的细胞死亡,称为细胞凋亡。细胞凋亡是由死亡配体或多种刺激因素启动的,包括化疗、伽玛刀照射等,在不同水平上受到多种机制的严格控制。在细胞内,Bcl2家族的成员构成了第一类调控蛋白,作用于线粒体水平。BAD是Bcl-2家族成员之一,在非磷酸化状态下对线粒体发挥促凋亡作用,并与Bel-xl或Bcl2形成失活二聚体促进细胞凋亡。磷酸化的BAD从与Bel-xl或Bcl2的异二聚体复合体解离,恢复Bel-xl或Bcl2的功能,并激活细胞生存信号。最近的研究表明,肿瘤细胞中激活的Bad激酶,包括Akt或PKA(A Kinase),通过BAD磷酸化在抵抗细胞凋亡中起关键作用。我们投资了…更多的是细胞内生存信号参与人肝细胞癌的发生。Akt和PKA都是。与邻近的非受累组织相比,在肝细胞癌中被激活。与未受累的肝脏相比,BAD蛋白在肝细胞癌中高度磷酸化。肝细胞中Akt和PKA活性与不良的磷酸化密切相关。此外,这些信号转导通路的抑制剂可诱导人肝癌细胞系的程序性细胞死亡。这些观察表明,生存信号通过不良的磷酸化抑制人肝癌细胞的程序性死亡,并提示它可能促进逃逸细胞凋亡以促进肝癌的进展。另一方面,丝裂原激活的蛋白激酶(MAPK)级联被激活以响应各种细胞外刺激。我们研究了p38MAPK,一个MAPK超家族,在人肝癌和肝癌细胞系中的级联作用。在肝细胞癌中,位于p38MAPK上游的MKK6和p38MAPK活性明显低于非肿瘤病变。P38MAPK与MKK6活性呈显著正相关。P38MAPK与caspase-3活性呈正相关。与较小的肿瘤相比,大于20 mm的HCCs显示出更低的MKK6和p38MAPK活性水平。MKK6基因表达上调肝癌细胞p38MAPK活性,细胞色素c从线粒体释放到胞浆,caspase-3活性增加,并伴有细胞凋亡。相反,p38 MAPK特异性抑制剂可阻止MKK6诱导的肝癌细胞系的凋亡。这些结果表明,p38MAPK级联信号通路与肝癌细胞程序性死亡通路的诱导是一致的,提示p38MAPK级联信号通路的减少可能在一定程度上是逃避细胞凋亡,导致人肝癌进展的原因之一。较少
项目成果
期刊论文数量(86)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Housui, A., et al.: "Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon -gamma stimuli"J.Biol.Chem.. 278. 28562-28571 (2003)
Housui, A., et al.:“丙型肝炎病毒核心蛋白在白细胞介素 6 和干扰素 -gamma 刺激下不同地调节 JAK-STAT 信号通路”J.Biol.Chem.. 278. 28562-28571 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yasumaru, M., et al.: "Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway"Cancer Res.. 63. 6726-6734 (2003)
Yasumaru, M., 等人:“抑制血管紧张素 II 活性可通过胰岛素样生长因子 I 受体途径增强环氧合酶 2 抑制剂的抗肿瘤作用”Cancer Res.. 63. 6726-6734 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Frontiers in Hepatology, HCV/Oxidative Stress and Liver Disease
肝病学、HCV/氧化应激和肝病前沿
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Ohkawa;K.;Housui;A.;Sasaki;Y.;Hayashi;N.
- 通讯作者:N.
Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats
- DOI:10.1152/ajpgi.00006.2002
- 发表时间:2002-12-01
- 期刊:
- 影响因子:4.5
- 作者:Komori, M;Tsuji, S;Hori, M
- 通讯作者:Hori, M
Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
- DOI:10.1016/s0016-5085(03)80280-9
- 发表时间:2003-04
- 期刊:
- 影响因子:11.2
- 作者:M. Yasumaru;S. Tsuji;M. Tsujii;T. Irie;M. Komori;A. Kimura;T. Nishida;Y. Kakiuchi;N. Kawai;H. Murata;M. Horimoto;Y. Sasaki;N. Hayashi;S. Kawano;M. Hori
- 通讯作者:M. Yasumaru;S. Tsuji;M. Tsujii;T. Irie;M. Komori;A. Kimura;T. Nishida;Y. Kakiuchi;N. Kawai;H. Murata;M. Horimoto;Y. Sasaki;N. Hayashi;S. Kawano;M. Hori
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SASAKI Yutaka其他文献
SASAKI Yutaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SASAKI Yutaka', 18)}}的其他基金
Scholarly Activities of the Social Science Research Council to Construct the Interdisciplinary Knowledge of the Social Sciences
社会科学研究会构建社会科学跨学科知识的学术活动
- 批准号:
19K01513 - 财政年份:2019
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of c-ktlow murine hematopoietic stem cells for the role in aged animals
c-ktlow 小鼠造血干细胞在老年动物中作用的研究
- 批准号:
25460483 - 财政年份:2013
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NMR of extremely diluted impurity helium-3in quantum solid helium-4
量子固体氦4中极稀杂质氦3的NMR
- 批准号:
22654039 - 财政年份:2010
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of compounded type Kansei presumption/automated design system and a Kansei communication interface
复合型感性推定/自动化设计系统及感性通信接口的开发
- 批准号:
21780239 - 财政年份:2009
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Analysis of mechanisms underlying treatment-resistance ofhepatocelluar carcinoma in the point view of post-translationalmodification evaluated by proteomics
从蛋白质组学翻译后修饰角度分析肝癌耐药机制
- 批准号:
21390230 - 财政年份:2009
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Exploration for novel murine hematopoietic stem cells by the use of intra-bone marrow injection methods
骨髓内注射新型小鼠造血干细胞的探索
- 批准号:
20591158 - 财政年份:2008
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of conductive ground using handheld loop-loop 3D electromagnetic method
使用手持式环路 3D 电磁法表征导电接地
- 批准号:
19560812 - 财政年份:2007
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
2/3-dimension dynamic expression analysis and automatic design for food and environment using expression information
利用表达信息进行食品和环境的2/3维动态表达分析和自动设计
- 批准号:
19780195 - 财政年份:2007
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Analysis of molecular mechanisms underlying apoptosis resistance of hepatocellular carcinoma using proteomics
蛋白质组学分析肝细胞癌凋亡抵抗的分子机制
- 批准号:
18390219 - 财政年份:2006
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Improving the reliability of airborne and ground-based electromagnetic surveys by 3-D inversion (Its application to landslide investigations)
通过 3-D 反演提高机载和地面电磁测量的可靠性(在滑坡调查中的应用)
- 批准号:
15560702 - 财政年份:2003
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
- 批准号:31970691
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
- 批准号:31900527
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
姜黄素与TRAIL的协同抗肿瘤机制研究
- 批准号:31101223
- 批准年份:2011
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
- 批准号:81100502
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Role for the Novel HAF-NFkappaB Axis in Driving Obesity-Associated Liver Cancer
新型 HAF-NFkappaB 轴在驱动肥胖相关肝癌中的作用
- 批准号:
10446842 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Immune profiling to detect viral hepatitis-related liver cancer in HIV-infected patients
免疫分析检测 HIV 感染者中病毒性肝炎相关肝癌
- 批准号:
10703227 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
A Role for the Novel HAF-NFkappaB Axis in Driving Obesity-Associated Liver Cancer
新型 HAF-NFkappaB 轴在驱动肥胖相关肝癌中的作用
- 批准号:
10676965 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Immune profiling to detect viral hepatitis-related liver cancer in HIV-infected patients
免疫分析检测 HIV 感染者中病毒性肝炎相关肝癌
- 批准号:
10536532 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Re-engineered Mitochondrially Targeted p53 Gene Therapy in Liver Cancer
重新设计的线粒体靶向 p53 基因疗法治疗肝癌
- 批准号:
10317129 - 财政年份:2021
- 资助金额:
$ 8.45万 - 项目类别:
Image-guided Interventional Combination Liver Cancer Immunotherapy
影像引导介入性肝癌联合免疫治疗
- 批准号:
10348797 - 财政年份:2021
- 资助金额:
$ 8.45万 - 项目类别:
Image-guided Interventional Combination Liver Cancer Immunotherapy
影像引导介入性肝癌联合免疫治疗
- 批准号:
10399666 - 财政年份:2021
- 资助金额:
$ 8.45万 - 项目类别:
Image-guided Interventional Combination Liver Cancer Immunotherapy
影像引导介入性肝癌联合免疫治疗
- 批准号:
10569648 - 财政年份:2021
- 资助金额:
$ 8.45万 - 项目类别:
ROS-induced SPIO Targeted Platform for Transarterial Liver Cancer Therapy
ROS诱导的SPIO靶向平台用于经动脉肝癌治疗
- 批准号:
10310481 - 财政年份:2021
- 资助金额:
$ 8.45万 - 项目类别:
PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION
PEA15 在肝癌发展中的作用及其治疗意义
- 批准号:
10329953 - 财政年份:2020
- 资助金额:
$ 8.45万 - 项目类别:














{{item.name}}会员




